Advertisement

Mycopathologia

, Volume 179, Issue 5–6, pp 415–424 | Cite as

Otomycosis in Iran: A Review

  • Maral Gharaghani
  • Zahra Seifi
  • Ali Zarei Mahmoudabadi
Article

Abstract

Fungal infection of the external auditory canal (otitis externa and otomycosis) is a chronic, acute, or subacute superficial mycotic infection that rarely involves middle ear. Otomycosis (swimmer’s ear) is usually unilateral infection and affects more females than males. The infection is usually symptomatic and main symptoms are pruritus, otalgia, aural fullness, hearing impairment, otorrhea, and tinnitus. Fungal species such as yeasts, molds, dermatophytes, and Malassezia species are agents for otitis externa. Among molds, Aspergillus niger was described as the most common agent in the literature. Candida albicans was more prevalent than other yeast species. Otomycosis has a worldwide distribution, but the prevalence of infection is related to the geographical location, areas with tropical and subtropical climate showing higher prevalence rates. Otomycosis is a secondary infection and is more prevalent among swimmers. As a result, a higher incidence is reported in summer season, when more people interested in swimming. Incidence of otomycosis in our review ranged from 5.7 to 81 %, with a mean value of 51.3 %. Our results showed that 78.59 % of otomycosis agents were Aspergillus, 16.76 % were Candida species, and the rest (4.65 %) were other saprophytic fungi. Among Iranian patients, incidence of infection was highest in summer, followed by autumn, winter, and spring. In Iran, otomycosis was most prevalent at the age of 20–40 years and the lowest prevalence was associated with being <10 years old. The sex ratio of otomycosis in our study was (M/F) 1:1.53.

Keywords

Otomycosis Aspergillus niger Yeasts Iran 

References

  1. 1.
    Bineshian F, Irajian G, Koochak-Alavi SK, Fredonian MR. A study on the frequency of fungal agents in otitis externa in Semnan. Iran J Pathol. 2006;1(4):141–4.Google Scholar
  2. 2.
    Saki N, Rafiei A, Nikakhlagh S, Amirrajab N, Saki S. Prevalence of otomycosis in Khouzestan province, south-west Iran. J Laryngol Otol. 2013;127(01):25–7.CrossRefPubMedGoogle Scholar
  3. 3.
    Munguia R, Daniel SJ. Ototopical antifungals and otomycosis: a review. Int J Pediatr Otorhinolaryngol. 2008;72(4):453–9.CrossRefPubMedGoogle Scholar
  4. 4.
    Nowrozi H, Arabi FD, Mehraban HG, Tavakoli A, Ghooshchi G. Mycological and clinical study of otomycosis in Tehran, Iran. Bull Environ Pharmacol Life Sci. 2014;3(2):29–31.Google Scholar
  5. 5.
    Barati B, Okhovvat S, Goljanian A, Omrani M. Otomycosis in central iran: a clinical and mycological study. Iran Red Crescent Med J. 2011;13(12):873–6.PubMedCentralPubMedGoogle Scholar
  6. 6.
    Vennewald I, Klemm E. Otomycosis: diagnosis and treatment. Clin Dermatol. 2010;28(2):202–11.CrossRefPubMedGoogle Scholar
  7. 7.
    Jia X, Liang Q, Chi F, Cao W. Otomycosis in Shanghai: aetiology, clinical features and therapy. Mycoses. 2012;55(5):404–9.CrossRefPubMedGoogle Scholar
  8. 8.
    Elahi S, Zaini F. First case report of otomycosis due to hendersonula toruloidea. Acta Med Iran. 1994;32:131–5.Google Scholar
  9. 9.
    Pakshir K, Sabayan B, Javan H, Karamifar K. Mycoflora of human external auditory canal in Shiraz, southern Iran. Iran Red Crescent Med J. 2008;10(1):27–9.Google Scholar
  10. 10.
    Kazemi AH, Ghiaei S. Survey of otomycosis in north-western area of Iran, 1997–2004. J Manzandaran Univ Med Sci. 2005;48:112–9.Google Scholar
  11. 11.
    Shokoohi T, Ahanjan M, Kasiri AM. Bacteriological and mycological study of external otitis in patients referred to ENT clinic of Boo Ali Sina hospital in Sari in summer 1999. J Mazandran Uni Med Sci. 2001;21:1–10.Google Scholar
  12. 12.
    Viswanatha B, Sumatha D, Vijayashree MS. Otomycosis in immunocompetent and immunocompromised patients: comparative study and literature review. Ear Nose Throat J. 2012;91(3):114–21.PubMedGoogle Scholar
  13. 13.
    Yeganeh Mogadam A, Asadi MA, Dehghani R, Hooshyar H. The prevalence of otomycosis in Kashan, Iran, during 2001–2003. Jundishapur J Microbiol. 2011;2(1):18–21.Google Scholar
  14. 14.
    Sheikh MS, Qazi B, Rameen B. Otomycosis in Khozistan. Indian J Otolaryngol Head Neck Surg. 1993;45(2):73–7.Google Scholar
  15. 15.
    Prasad SC, Kotigadde S, Shekhar M, Thada ND, Prabhu P, D’Souza T. et al. (2014) Primary otomycosis in the Indian subcontinent: predisposing factors, microbiology, and classification. Int J Microbiol. 2014:Article ID 636493Google Scholar
  16. 16.
    Anwar K, Gohar MS. Otomycosis; clinical features, predisposing factors and treatment implications. Pak J Med Sci. 2014;30(3):564–7.PubMedCentralPubMedGoogle Scholar
  17. 17.
    Latha R, Sasikala R, Muruganandam N. Chronic otomycosis due to Malassezia spp. J Global Infect Dis. 2010;2(2):189–90.CrossRefGoogle Scholar
  18. 18.
    Sephidgar A, Kyakajouri K, Meyrzaei M, Sharifi F. Fungal infections of external ear canal in patients with otomycosis, Babol, 1991–2001. J Babol Med Sci. 2002;4(1):25–9.Google Scholar
  19. 19.
    Zarei Mahmoudabadi A, Abshirini H, Rahimi R. Fungal flora of hearing aid moulds and ear canal in hearing aid wearers in school children in Ahvaz, Iran. Jundishapur J Microbiol. 2009;2(1):22–4.Google Scholar
  20. 20.
    Zarei Mahmoudabadi A, Masoomi SA, Mohammadi H. Clinical and mycological studies of otomycosis. Pak J Med Sci. 2010;26(1):187–90.Google Scholar
  21. 21.
    Kaur R, Mittal N, Kakkar M, Aggarwal AK, Mathur MD. Otomycosis: a clinicomycologic study. Ear Nose Throat J. 2000;79(8):606–9.PubMedGoogle Scholar
  22. 22.
    Sturgulewski SK, Bankaitis A, Klodd DA, Haberkamp T. What’s still growing on your patients’ hearing aids? Hear J. 2006;59(9):45–6.CrossRefGoogle Scholar
  23. 23.
    Ozcan KM, Ozcan M, Karaarslan A, Karaarslan F. Otomycosis in Turkey: predisposing factors, aetiology and therapy. J Laryngol Otol. 2003;117(01):39–42.CrossRefPubMedGoogle Scholar
  24. 24.
    Paulose K, Khalifa SA, Shenoy P, Sharma R. Mycotic infection of the ear (otomycosis): a prospective study. J Laryngol Otol. 1989;103(01):30–5.CrossRefPubMedGoogle Scholar
  25. 25.
    Jackman A, Ward R, April M, Bent J. Topical antibiotic induced otomycosis. Int J Pediatr Otorhinolaryngol. 2005;69(6):857–60.CrossRefPubMedGoogle Scholar
  26. 26.
    Ghiacei S. Survey of otomycosis in north-western area of Iran. Med J Mashhad Univ Med Sci. 2001;43:85–7.Google Scholar
  27. 27.
    Pontes ZBVdS, Silva ADF, Lima EDO, Guerra MDH, Oliveira NMC, Carvalho MDFFP, et al. Otomycosis: a retrospective study. Braz J Otorhinolaryngol. 2009;75(3):367–70.CrossRefPubMedGoogle Scholar
  28. 28.
    Szigeti G, Sedaghati E, Zarei Mahmoudabadi A, Naseri A, Kocsube S, Vágvölgyi C, et al. Species assignment and antifungal susceptibilities of black aspergilli recovered from otomycosis cases in Iran. Mycoses. 2012;55(4):333–8.CrossRefPubMedGoogle Scholar
  29. 29.
    Kiakojuri K, Roushan MRH, Sepidgar SAA. Suction clearance and 2 % topical miconazole versus the same combination with acidic drops in the treatment of otomycosis. Southeast Asian J Trop Med Public Health. 2007;38:749–53.PubMedGoogle Scholar
  30. 30.
    Chadeganipour M, Shadzi S, Nilipour S, Ahmadi G. Airborne fungi in Isfahan and evaluation of allergenic responses of their extracts in animal model. Jundishapur J Microbiol. 2011;3(4):155–60.Google Scholar
  31. 31.
    Rajabnia R, Mahdavi Omran S, Majidian A, Aghajanpour S, Kiakojori K. Comparison of fungal flora in patients with acute otitis externa and healthy subjects. J Babol Univ Med Sci. 2010;12(3):32–7.Google Scholar
  32. 32.
    Moharram AM, Ahmed HE, Salma AMN. Otomycosis in Assiut, Egypt. J Basic Appl Mycol (Egypt). 2013;4:1–11.Google Scholar
  33. 33.
    Değerli K, Ecemiş T, Günhan K, Başkesen T, Kal E. Agents of otomycosis in Manisa region, Turkey, 1995–2011. Mikrobiyol Bul. 2012;46(1):79–87.PubMedGoogle Scholar
  34. 34.
    García-Agudo L, Aznar-Marín P, Galán-Sánchez F, García-Martos P, Marín-Casanova P, Rodríguez-Iglesias M. Otomycosis due to filamentous fungi. Mycopathologia. 2011;172(4):307–10.CrossRefPubMedGoogle Scholar
  35. 35.
    Badr Jabir H, Naeem Abbas F, Muhsin Khalaf R. In vitro assessment of antifungal potential of apple cider vinegar and acetic acid versus fluconazole in clinical isolates of otomycosis. Thi Qar Med J. 2011;5(1):126–33.Google Scholar
  36. 36.
    Fayemiwo S, Ogunleye V, Adeosun A, Bakare R. Prevalence of otomycosis in Ibadan: a review of laboratory reports. Afr J Med Med Sci. 2010;39:219–22.PubMedGoogle Scholar
  37. 37.
    Kiakojuri K, Rajabnia R, Jalili B, Khafri S, Mahdavi Omran SS. Otomycosis in adolescent patients who referred to therapeutical centers, Babol, report of 56 cases. Jundishapur J Microbiol 2015;8:17138 (in press).Google Scholar
  38. 38.
    Berjis N, Okhovat SA, Soleimani Koujani Z, Baradaran S. Comparing the therapeutic effect of clotrimazole and tolnaftate in treating the variety of fungal species producing otomycosis in two educational hospital, Isfahan, Iran. J Isfahan Med Sch. 2012;29(164):2117–26.Google Scholar
  39. 39.
    Ettehad GH, Refahi S, Nemmati A, Pirzadeh A, Daryani A. Microbial and antimicrobial susceptibility patterns from patients with chronic otitis media in Ardebil. Int J Trop Med. 2006;1(2):62–5.Google Scholar
  40. 40.
    Mikaeili A, Nazari S. Aspergillus and otomycosis in Kermanshah Iran. 5th Advances against Aspergillosis, 26–28 January 2012—Istanbul, Turkey. 2012Google Scholar
  41. 41.
    Balouchi M, Berjis N, Okhovat A. Investigation of ear fungal infection. J Isfahan Med Sch. 2006;82(4):72–5.Google Scholar
  42. 42.
    Nemati S, Hassanzadeh R, Jahromi SK, Abadi ADN. Otomycosis in the north of Iran: common pathogens and resistance to antifungal agents. Eur Arch Otorhino Laryngol. 2014;271(5):953–7.CrossRefGoogle Scholar
  43. 43.
    Kiakojuri K, Roushan MRH, Sepidgar SAA. Suction clearance and 2% topical miconazole versus the same combination with acidic drops in the treatment of otomycosis. Southeast Asian J Trop Med Public Health. 2007;38:749–53.PubMedGoogle Scholar
  44. 44.
    Afshari MA, Kachooei R, Ajalloeian M. Assessment of prevalence of otomycosis in ENT clinic in Baqiyatallah (AS) hospital. J Mil Med. 2005;2:121–4.Google Scholar
  45. 45.
    Jalali MM, Kousha AAR, Hashemi SJ, Forghan Parast K, Karimi HR. Frequency of fungi in the middle ear effusion of patients suffering from serous otitis media in Rasht Amiralmomenin hospital (2004–2005). J Ilam Univ Med Sci. 2006;14(1):39–43.Google Scholar
  46. 46.
    Zarei Mahmoudabadi A. Mycological studies in 15 cases of otomycosis. Pak J Med Sci. 2006;22(4):486–8.Google Scholar
  47. 47.
    Yaganeh Moghadam A, Asadi M, Dehghani R, Zarei Mahmoudabadi A, Rayegan F, Hooshyar H, Khorshidi A. Evaluating the effect of a mixture of alcohol and acetic acid for otomycosis therapy. Jundishapur J Microbiol. 2010;3(2):66–70.Google Scholar
  48. 48.
    Desai KJ, Malek SS, Italia IK, Jha S, Pndya V, Shah H. Fungal spectrum in otomycosis at tertiary care hospital. Natl J Integr Res Med. 2012;3(5):58–61.Google Scholar
  49. 49.
    Aneja K, Sharma C, Joshi R. Fungal infection of the ear: a common problem in the north eastern part of Haryana. Int J Pediatr Otorhinolaryngol. 2010;74(6):604–7.CrossRefPubMedGoogle Scholar
  50. 50.
    Adoubryn K, N’gattia V, Kouadio-Yapo G, Nigué L, Zika D, Ouhon J. Epidemiology of otomycoses at the university hospital of Yopougon (Abidjan-Ivory Coast). J Mycol Med. 2014;24(2):e9–15.CrossRefPubMedGoogle Scholar
  51. 51.
    Deshmukh J, Surpam R, Band A, Jalgaon KD, India M. Mycological study of Aspergillus infections in otomycosis in eastern part of Maharashtra. Int J Health Sci Res. 2014;4(10):77–82.Google Scholar
  52. 52.
    Gutiérrez PH, Álvarez SJ, Sanudo E, García LG-C, Sánchez CR, VallejoValdezate L. Presumed diagnosis: otomycosis. A study of 451 patients. Acta Otorrinolaringol Esp. 2005;56:181–6.CrossRefGoogle Scholar
  53. 53.
    Panchal P, Pethani J, Patel D, Rathod S, Shah P. Analysis of various fungal agents in clinically suspected cases of otomycosis. Indian J Basic Appl Med Res. 2013;2:865–9.Google Scholar
  54. 54.
    Zarei Mahmoudabadi A, Seifi Z, Gharaghani M. Lamisil, a potent alternative antifungal drug for otomycosis. Adv Med Mycol. 2015;1(1):18–21.Google Scholar
  55. 55.
    Sagit M, Somdas MA, Korkmaz F, Akcadag A. The ototoxic effect of intratympanic terbinafine applied in the middle ear of rats. J Otolaryngol Head Neck Surg. 2013;42(1):13.CrossRefPubMedCentralPubMedGoogle Scholar
  56. 56.
    Alnawaiseh S, Almomani O, Alassaf S, Elessis A, Shawakfeh N, Altubeshi K, et al. Treatment of otomycosis: a comparative study using miconazole cream with clotrimazole otic drops. J Roy Med Serv. 2011;18(3):34–7.Google Scholar
  57. 57.
    Philip A, Thomas R, Job A, Sundaresan VR, Anandan S, Albert RR. Effectiveness of 7.5 percent povidone iodine in comparison to 1 percent clotrimazole with lignocaine in the treatment of otomycosis. ISRN Otolaryngol. 2013. doi: 10.1155/2013/239730.
  58. 58.
    Zarei Mahmoudabadi A, Abshirini H, Ahmadi K, Moghimipour E. Lamisil ear drop, a newly prepared antifungal for otomycosis treatment. In: The 3rd Iranian Congress of Clinical Microbiology (ICCM), Shiraz, Iran, 6–8 Oct, 2009. (Abstract book), p. 40.Google Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2015

Authors and Affiliations

  • Maral Gharaghani
    • 1
  • Zahra Seifi
    • 2
  • Ali Zarei Mahmoudabadi
    • 1
    • 2
  1. 1.Department of Medical Mycology, School of MedicineAhvaz Jundishapur University of Medical SciencesAhvazIran
  2. 2.Health Research Institute, Infectious and Tropical Diseases Research CentreAhvaz Jundishapur University of Medical SciencesAhvazIran

Personalised recommendations